ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
ZUMA-5 update: Axicabtagene ciloleucel continues to show strong effect in R/R iN...
Prof Sattva Neelapu - The University of Texas MD Anderson Cancer Center, Houston...
Lisocabtagene maraleucel demonstrates improvement over standard of care in 2L LB...
Dr Manali Kamdar - The University of Colorado Anschutz Medical Campus, Aurora, U...
Latest in advanced endometrial cancer
Prof Isabelle Ray-Coquard, Prof Christian Marth, Prof David Cibula, Prof Ignace ...
Post-HSCT management of ALL - Adult ALL perspective
Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain
Safety profile of BiTE therapy
Dr Arend von Stackelberg - Charité Universitätsmedizin, Berlin, Germany
Cancer drug policy and access in LMICs
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Anti-CD38 immunotherapy treatment for multiple myeloma
Prof Xavier Leleu - CHU de Poitiers, Poitiers, France
Paediatric ALL perspective
Prof Andrea Biondi - University of Milano-Bicocca, Milan, Italy
Immunotherapy of T-ALL: Opportunities and hurdles
Dr Maksim Mamonkin - Baylor College of Medicine, Houston, USA
Managing immune-related adverse effects in Africa
Dr Mohammed Ezzi- University of Nairobi, Nairobi, Kenya
What to look forward to at AORTIC 2021
Dr Nazik Hammad - Queen's University, Kingston, Canada
Identifying and treating high-risk/MRD positive newly diagnosed multiple myeloma
Prof Wee Joo Chng - National University Cancer Institute, Singapore